Related references
Note: Only part of the references are listed.The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
A frontier in the understanding of synaptic plasticity: Solving the structure of the postsynaptic density
Matthew G. Gold
BIOESSAYS (2012)
Targeting glutamate system for novel antipsychotic approaches: Relevance for residual psychotic symptoms and treatment resistant schizophrenia
Andrea de Bartolomeis et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor
Andrea de Bartolomeis et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions
Sudarshana Purkayastha et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Calcium-Dependent Networks in Dopamine-Glutamate Interaction: The Role of Postsynaptic Scaffolding Proteins
Andrea de Bartolomeis et al.
MOLECULAR NEUROBIOLOGY (2012)
Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain
Douglas J. Cook et al.
NATURE (2012)
Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades
Hannah K. Delille et al.
NEUROPHARMACOLOGY (2012)
Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine
Ming-Huan Chan et al.
SCHIZOPHRENIA RESEARCH (2012)
Pharmacological characterizations of memantine-induced disruption of prepulse inhibition of the acoustic startle response in mice: Involvement of dopamine D2 and 5-HT2A receptors
Kota Nakaya et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs
Miguel Fribourg et al.
CELL (2011)
Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of δ-opioid receptor
Maria C. Olianas et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Effect of clozapine on the dimerization of serotonin 5-HT2A receptor and its genetic variant 5-HT2AH425Y with dopamine D2 receptor
Sylwia Lukasiewicz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Serotonin 2A receptor antagonists for treatment of schizophrenia
Bjorn H. Ebdrup et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Abnormalities in α/β-CaMKII and related mechanisms suggest synaptic dysfunction in hippocampus of LPA1 receptor knockout mice
Laura Musazzi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania
Mikhail Kalinichev et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Regulation of Akt and Wnt signaling by the group II metabotropic glutamate receptor antagonist LY341495 and agonist LY379268
Laurie P. Sutton et al.
JOURNAL OF NEUROCHEMISTRY (2011)
The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats
M. Horiguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients
Ilja Spellmann et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes
Felice Iasevoli et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability
Robin L. Carhart-Harris et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis
P. Fusar-Poli et al.
MOLECULAR PSYCHIATRY (2011)
Characterization of the proteome, diseases and evolution of the human postsynaptic density
Alex Bayes et al.
NATURE NEUROSCIENCE (2011)
An animal model of schizophrenia based on chronic LSD administration: Old idea, new results
Danuta Marona-Lewicka et al.
NEUROPHARMACOLOGY (2011)
Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors
Laura Albizu et al.
NEUROPHARMACOLOGY (2011)
The Presynaptic Component of the Serotonergic System is Required for Clozapine's Efficacy
Prem N. Yadav et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Group II Metabotropic Glutamate Receptor Agonist Ameliorates MK801-Induced Dysfunction of NMDA Receptors via the Akt/GSK-3β Pathway in Adult Rat Prefrontal Cortex
Dong Xi et al.
NEUROPSYCHOPHARMACOLOGY (2011)
ATTENTION DEFICIT INDUCED BY BLOCKADE OF N-METHYL D-ASPARTATE RECEPTORS IN THE PREFRONTAL CORTEX IS ASSOCIATED WITH ENHANCED GLUTAMATE RELEASE AND cAMP RESPONSE ELEMENT BINDING PROTEIN PHOSPHORYLATION: ROLE OF METABOTROPIC GLUTAMATE RECEPTORS 2/3
L. Pozzi et al.
NEUROSCIENCE (2011)
Methylation of the CpG Sites Only on the Sense Strand of the APC Gene Is Specific for Hepatocellular Carcinoma
Surbhi Jain et al.
PLOS ONE (2011)
DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia
Giuseppe Blasi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes
Carmine Tomasetti et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice
Adam L. Halberstadt et al.
PSYCHOPHARMACOLOGY (2011)
Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats
Avi E. Zayara et al.
PSYCHOPHARMACOLOGY (2011)
Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats
Masakuni Horiguchi et al.
PSYCHOPHARMACOLOGY (2011)
Density of metabotropic glutamate receptors 2 and 3 (mGluR2/3) in the dorsolateral prefrontal cortex does not differ with schizophrenia diagnosis but decreases with age
Elisabeth Frank et al.
SCHIZOPHRENIA RESEARCH (2011)
Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat
Claire E. McKibben et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Dopamine D2 and 5-hydroxytryptamine 5-HT2A receptors assemble into functionally interacting heteromers
Dasiel O. Borroto-Escuela et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Hetero-dimerization of serotonin 5-HT2A and dopamine D2 receptors
Sylwia Lukasiewicz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex
Xavier Lopez-Gil et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Association between AKT1 but not AKTIP genetic variants and increased risk for suicidal behavior in bipolar patients
L. A. V. Magno et al.
GENES BRAIN AND BEHAVIOR (2010)
Serotonin, But Not N-Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex In Vivo
Cullen L. Schmid et al.
JOURNAL OF NEUROSCIENCE (2010)
Treatment with Olanzapine is Associated with Modulation of the Default Mode Network in Patients with Schizophrenia
Fabio Sambataro et al.
NEUROPSYCHOPHARMACOLOGY (2010)
A CYCLIC PEPTIDE TARGETED AGAINST PSD-95 BLOCKS CENTRAL SENSITIZATION AND ATTENUATES THERMAL HYPERALGESIA
B. W. LeBlanc et al.
NEUROSCIENCE (2010)
SELECTIVE POTENTIATION OF THE METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 2 BLOCKS PHENCYCLIDINE-INDUCED ACTIVATION HYPERLOCOMOTION AND BRAIN
E. A. Hackler et al.
NEUROSCIENCE (2010)
Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions
Felice Iasevoli et al.
PSYCHIATRY RESEARCH (2010)
LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor
Adam L. Halberstadt et al.
PSYCHOPHARMACOLOGY (2010)
Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats
Vera Bubenikova-Valesova et al.
PSYCHOPHARMACOLOGY (2010)
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole
Felice Iasevoli et al.
PSYCHOPHARMACOLOGY (2010)
Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain
Xanthi Antoniou et al.
PHARMACEUTICALS (2010)
Differential Expression of Metabotropic Glutamate Receptors 2 and 3 in Schizophrenia: A Mechanism for Antipsychotic Drug Action?
Subroto Ghose et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Evaluation of NMDA receptor models of schizophrenia: Divergences in the behavioral effects of sub-chronic PCP and MK-801
Alexandre Seillier et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia
Alessandro Bertolino et al.
BRAIN (2009)
Antipsychotic and antidepressant co-treatment: Effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders
Carmela Dell'Aversano et al.
BRAIN RESEARCH BULLETIN (2009)
PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors
Atheir I. Abbas et al.
JOURNAL OF NEUROSCIENCE (2009)
Chronic infusion of PCP via osmotic mini-pumps: A new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance
Christian Spang Pedersen et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
Building a new conceptual framework for receptor heteromers
Sergi Ferre et al.
NATURE CHEMICAL BIOLOGY (2009)
OPINION The 'atypicality' of antipsychotics: a concept re-examined and re-defined
Gerhard Gruender et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Differential expression of glutamate transporter genes after chronic oral treatment with aripiprazole in rats
Nina Segnitz et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Protein-protein interactions as therapeutic targets in neuropsychopharmacology
Matthew T. Reilly et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Antipsychotic drug actions on gene modulation and signaling mechanisms
Raffaella Molteni et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia-a postmortem study
Kai Kang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action
Felice Iasevoli et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Changes in prefrontal and amygdala activity during olanzapine treatment in schizophrenia
Giuseppe Blasi et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D-1 and serotonin 5-HT1A receptors
Taku Nagai et al.
PSYCHOPHARMACOLOGY (2009)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-monitoring
Klaas E. Stephan et al.
SCHIZOPHRENIA BULLETIN (2009)
Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages
Andrew Gray et al.
VACCINE (2009)
Molecular biology of 5-HT receptors
Jason Hannon et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology
Andrea Gogos et al.
BEHAVIOURAL PHARMACOLOGY (2008)
On the fitting of binding data when receptor dimerization is suspected
J. Giraldo
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Identification of a serotonin/glutamate receptor complex implicated in psychosis
Javier Gonzalez-Maeso et al.
NATURE (2008)
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride:: An iodine-123-iodobenzamide SPET study
E. M. Meisenzahl et al.
PHARMACOPSYCHIATRY (2008)
Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics
Bernard Masri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: A locomotor activity and gene induction study
Mikhail Kalinichev et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists:: [11C] raclopride PET studies in the rat
Alice Egerton et al.
PSYCHOPHARMACOLOGY (2008)
Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat
Hong-Shuo Sun et al.
STROKE (2008)
Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors:: G-protein activation and K+ channel modulation in transfected cells
Adrian Newman-Tancredi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist
Michael A. Benneyworth et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Stress-induced dopamine release in humans at risk of psychosis:: a [11C]raclopride PET study
Alexandra Soliman et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Chronic antidepressants induce redistribution and differential activation of αCaM kinase II between presynaptic compartments
Valentina S. Barbiero et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: Implication for glutamatergic postsynaptic density in antipsychotics action
C. Tomasetti et al.
NEUROSCIENCE (2007)
Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat
B. Grayson et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Clozapine and haloperidol differently suppress the MK-801-Increased Glutamatergic and Serotonergic transmission in the medial prefrontal cortex of the rat
Xavier Lopez-Gil et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Long-term soluble Aβ1-40 activates CaM kinase II in organotypic hippocampal cultures
Daniela Tardito et al.
NEUROBIOLOGY OF AGING (2007)
A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis
Michael A. Benneyworth et al.
MOLECULAR PHARMACOLOGY (2007)
Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics
Michael Didriksen et al.
PSYCHOPHARMACOLOGY (2007)
Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum
Evgeny Bychkov et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Delayed alternation performance following subchronic phencyclidine administration in rats depends on task parameters
Jean-Philippe Marquis et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT2A/2C receptors
Yun-Ai Su et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Differential expression of Homer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain
Alberto Ambesi-Impiombato et al.
SYNAPSE (2007)
F15063, a compound with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties:: (II) Activity in models of positive symptoms of schizophrenia
R. Depoortere et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Ketamine-related expression of glutamatergic postsynaptic density genes: Possible implications in psychosis
Felice Iasevoli et al.
NEUROSCIENCE LETTERS (2007)
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
Susheel Vijayraghavan et al.
NATURE NEUROSCIENCE (2007)
Complex, multimodal behavioral profile of the Homer1 knockout mouse
P. J. Jaubert et al.
GENES BRAIN AND BEHAVIOR (2007)
Habituation deficits induced by metabotropic glutamate receptors 2/3 receptor blockade in mice:: Reversal by antipsychotic drugs
Anton Bespalov et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics
Xiaohua Li et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior
Javier Gonzalez-Maeso et al.
NEURON (2007)
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
Jean-Martin Beaulieu et al.
JOURNAL OF NEUROSCIENCE (2007)
Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization
Pei-Chun Chen et al.
JOURNAL OF NEUROCHEMISTRY (2007)
WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity
Karen L. Marquis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Lifetime prevalence of psychotic and bipolar I disorders in a general population
Jonna Perala et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Haloperidol induces neurotoxicity by the NMDA receptor downstream signaling pathway, alternative from glutamate excitotoxicity
E. Zhuravliova et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Opposite effects of PSD-95 and MPP3 PDZ proteins on serotonin 5-hydroxytryptamine2C receptor desensitization and membrane stability
Sophie Gavarini et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice
Jean-Martin Beaulieu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity
Estela Jacinto et al.
CELL (2006)
Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine2A receptor inverse agonist
KE Vanover et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers
JY Springael et al.
MOLECULAR PHARMACOLOGY (2006)
5-Hydroxytryptamine 1A receptor blockade facilitates aversive learning in mice:: Interactions with cholinergic and glutamatergic mechanisms
N Madjid et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function
KD Lominac et al.
JOURNAL OF NEUROSCIENCE (2005)
Break on through to the other side - Biophysics and cell biology shed light on cell-penetrating peptides
R Fischer et al.
CHEMBIOCHEM (2005)
Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): A double-blind, cross-over study in healthy volunteers
E Gouzoulis-Mayfrank et al.
PHARMACOPSYCHIATRY (2005)
KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia
WK Park et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin
PR Lee et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Role of 5-HT2Aand 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats
KT Ball et al.
PSYCHOPHARMACOLOGY (2005)
The effects of antipsychotics on β-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats
H Alimohamad et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Effects of donepezil, nicotine and haloperidol on the central serotonergic system in mice: Implications for Tourette's syndrome
RL Hayslett et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Principles: A model for the allosteric interactions between ligand binding sites within a dimeric GPCR
T Durroux
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism
EY Yuen et al.
JOURNAL OF NEUROSCIENCE (2005)
5-HT2A and muscarinic receptors in schizophrenia:: a postmortem study
I Matsumoto et al.
NEUROSCIENCE LETTERS (2005)
Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat
M Lüttgen et al.
NEUROPHARMACOLOGY (2005)
The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating
V Bubeníková et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Antipsychotics alter the protein expression levels of β-catenin and GSK-3 in the rat medial prefrontal cortex and striatum
H Alimohamad et al.
BIOLOGICAL PSYCHIATRY (2005)
Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats
B Pouzet et al.
PSYCHOPHARMACOLOGY (2005)
Dopamine-glutamate interaction and antipsychotics mechanism of action: Implication for new pharmacological strategies in psychosis
A de Bartolomeis et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
JM Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Constitutive activity of the serotonin2c receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens
P De Deurwaerdère et al.
JOURNAL OF NEUROSCIENCE (2004)
Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice
SA Brody et al.
PSYCHOPHARMACOLOGY (2004)
Metabotropic glutamate 2/3 receptors as drug targets
GJ Marek
CURRENT OPINION IN PHARMACOLOGY (2004)
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
ES Emamian et al.
NATURE GENETICS (2004)
A glycogen synthase kinase 3-β promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression
F Benedetti et al.
NEUROSCIENCE LETTERS (2004)
In vivo regulation of glycogen synthase kinase-3β (GSK3β) by serotonergic activity in mouse brain
XH Li et al.
NEUROPSYCHOPHARMACOLOGY (2004)
AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
TD Gould et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
GPCR-interacting proteins (GIPs):: nature and functions
J Bockaert et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers
CJA Morgan et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation
E Tiraboschi et al.
NEUROREPORT (2004)
Protein phosphatase 2A negatively Akt (protein kinase B) activity in 3T3-L1 adipocytes
S Ugi et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin:: 24-h follow-up studies
PA Broderick et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Role of serotonin2A receptors in the D-amphetamine-induced release of dopamine:: comparison with previous data on α1b-adrenergic receptors
A Auclair et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Diverse psychotomimetics act through a common signaling pathway
P Svenningsson et al.
SCIENCE (2003)
Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia
A Abi-Dargham et al.
NEUROSCIENTIST (2003)
At as a mediator of cell death
HR Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mutation screening of the Homer gene family and association analysis in schizophrenia
N Norton et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction
ZQ Xia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration
CD Nichols et al.
MOLECULAR BRAIN RESEARCH (2003)
The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism
GA Higgins et al.
PSYCHOPHARMACOLOGY (2003)
Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: Modulation by a group II selective metabotropic glutamate receptor agonist LY379268
DS Lorrain et al.
NEUROSCIENCE (2003)
Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions
M Aarts et al.
SCIENCE (2002)
The selective serotonin1A-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase
CP Müller et al.
BEHAVIOURAL BRAIN RESEARCH (2002)
A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain
CD Nichols et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Acute administration of antipsychotics modulates Homer striatal gene expression differentially
A de Bartolomeis et al.
MOLECULAR BRAIN RESEARCH (2002)
Localization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group
C Nocjar et al.
NEUROSCIENCE (2002)
GSK3 takes centre stage more than 20 years after its discovery
S Frame et al.
BIOCHEMICAL JOURNAL (2001)
5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation:: a possible mechanism of atypical antipsychotic-induced cortical dopamine release
J Ichikawa et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers -: Implications for models of cognitive deficits in schizophrenia
D Umbricht et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Striatal and extra-striatal D2/D3 dopamine receptor occupancy by quetiapine in vivo -: [123I]-epidepride single photon emission tomography (SPET) study
CME Stephenson et al.
BRITISH JOURNAL OF PSYCHIATRY (2000)
Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors
JC Gewirtz et al.
NEUROPSYCHOPHARMACOLOGY (2000)
5-HT1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex
H Rollema et al.
BIOLOGICAL PSYCHIATRY (2000)
Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area
MD Doherty et al.
BRAIN RESEARCH (2000)
Low GSK-3β immunoreactivity in postmortem frontal cortex of schizophrenic patients
N Kozlovsky et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo
HL Rowley et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)
Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated
G Lucas et al.
NEUROPHARMACOLOGY (2000)
Share Paper
